| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Alnylam Pharmaceuticals, Inc. | $278.09 | -1.6% | $37.1B | 119.4 | 301.4% | — | Healthcare | -11% | 82.6% | ||
| 2 | Ionis Pharmaceuticals, Inc. | $74.12 | -0.3% | $12.25B | -31.1 | 30.1% | — | Healthcare | 100.3% | 47.5% | ||
| 3 | Arrowhead Pharmaceuticals, Inc. | $81.82 | 1% | $11.52B | -6706.6 | -50.7% | — | Healthcare | 423.8% | 14.1% | ||
| 4 | CRISPR Therapeutics AG | $54.09 | 1.9% | $5.22B | -8.4 | -37.6% | — | Healthcare | 21.7% | -88.9% | ||
| 5 | Beam Therapeutics Inc. | $34.14 | 5.1% | $3.51B | -42.1 | 85.2% | — | Healthcare | 100.9% | 108% | ||
| 6 | Stoke Therapeutics, Inc. | $31.00 | 2.4% | $1.93B | -258.3 | -458.2% | — | Healthcare | 167.9% | -83.2% | ||
| 7 | Intellia Therapeutics, Inc. | $15.67 | 3.1% | $1.76B | -4.1 | 32.3% | — | Healthcare | 63.2% | 45% | ||
| 8 | Wave Life Sciences Ltd. | $6.16 | 3.5% | $1.19B | -5.1 | -26.2% | — | Healthcare | -10.7% | -31.6% | ||
| 9 | Arbutus Biopharma Corporation | $4.55 | 2.7% | $899M | -26.8 | 302.1% | — | Healthcare | 31.1% | 2889.9% | ||
| 10 | Design Therapeutics, Inc. | $12.44 | 4.3% | $777M | -10.2 | -21.2% | — | Healthcare | 228.2% | — | ||
| 11 | Prime Medicine, Inc. | $3.23 | 2.2% | $583M | -2.4 | 23.5% | — | Healthcare | 79.4% | 4.9% | ||
| 12 | Silence Therapeutics plc | $6.93 | 1.2% | $327M | -3.7 | -1.7% | — | Healthcare | 22.4% | -96.8% | ||
| 13 | Editas Medicine, Inc. | $2.69 | 5.5% | $263M | -1.5 | 59.6% | — | Healthcare | 14.5% | 8% | ||
| 14 | Atrium Therapeutics, Inc. | $12.66 | 1.4% | $217M | -2.8 | -71.1% | — | Healthcare | -56.8% | 312.4% | ||
| 15 | Arcturus Therapeutics Holdings Inc. | $7.53 | 2.3% | $214M | -3.1 | -11.9% | — | Healthcare | -39% | -66.4% | ||
| 16 | ProQR Therapeutics N.V. | $1.89 | 13.2% | $199M | -4.3 | -27.1% | — | Healthcare | -2.6% | -29.2% | ||
| 17 | Korro Bio, Inc. | $12.99 | 17.6% | $129M | -1.0 | -23.7% | — | Healthcare | 4.3% | -20.3% | ||
| 18 | PepGen Inc. | $1.79 | 5.3% | $124M | -0.8 | 32.9% | — | Healthcare | 21.8% | — | ||
| 19 | CAMP4 Therapeutics Corporation | $4.13 | -0.2% | $88M | -1.6 | 19.2% | — | Healthcare | 201.5% | 160.5% | ||
| 20 | Precision BioSciences, Inc. | $6.81 | 4.8% | $87M | -1.9 | -57% | — | Healthcare | 44.9% | -11.9% | ||
| 21 | Sangamo Therapeutics, Inc. | $0.18 | 0.8% | $75M | -0.4 | 2.2% | — | Healthcare | -63.3% | -45.8% | ||
| 22 | Metagenomi, Inc. Common Stock | $1.20 | 1.7% | $45M | -0.5 | -9% | — | Healthcare | -18.9% | -50.7% | ||
| 23 | Aligos Therapeutics, Inc. | $5.28 | -1.3% | $33M | -2.2 | 50.2% | — | Healthcare | -36.9% | 43.9% | ||
| 24 | Exicure, Inc. | $2.40 | 14.3% | $15M | -3.0 | -67.5% | — | Healthcare | -68.5% | — | ||
| 25 | Phio Pharmaceuticals Corp. | $1.03 | -4.6% | $12M | -0.7 | 100% | — | Healthcare | -56.4% | — | ||
| 26 | TransCode Therapeutics, Inc. | $4.70 | -12.1% | $4M | -0.1 | 49.3% | — | Healthcare | -32.7% | — | ||
| 27 | Silexion Therapeutics Ltd. | $2.73 | -5.9% | $881891 | -0.0 | 403.1% | — | Healthcare | -97.8% | — | ||
| 28 | Silexion Therapeutics Ltd. | $0.04 | 75.4% | $14278 | -0.0 | 403.1% | — | Healthcare | -12% | — |